This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Penicillins during breastfeeding

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

All penicillin antibitotics can be used during breastfeeding with precautionary infant monitoring (1):

  • flucloxacillin, phenoxymethylpenicillin (penicillin V) and the broad-spectrum penicillins, such as amoxicillin and ampicillin, are the preferred choices as there is more evidence and experience to support their use
  • pharmacokinetic properties and characteristics of all the penicillins are very similar
  • although protein binding and bioavailability vary between the different penicillins, they are all acidic in nature and therefore only negligible quantities pass into milk
    • drugs cross membranes in an un-ionised form (2)
      • milk is generally slightly more acidic (pH 7.2) than the mother’s plasma (pH 7.4) so it attracts weak organic bases such as oxycodone and codeine
        • such drugs become ionised and ‘trapped’ in the milk
        • conversely, weak organic acids such as penicillin tend to be ionised and held in maternal plasma
    • occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with penicillins, but these effects have not been adequately evaluated (3)
    • has been the occasional case report of rash, nausea, irritability and drowsiness; these were usually mild and self-limiting, and could be attributable to other causes (1)
  • treatment choice should be primarily based on clinical indications and in line with national and local antimicrobial policy, with suitability in breastfeeding as a secondary consideration (1)
    • ideally treatment should be at the lowest therapeutic dose for shortest duration of time

Use of combination penicillin preparations during breastfeeding

  • some penicillins are combined with beta-lactamase inhibitors such as clavulanic acid (co-amoxiclav) or tazobactam (combined with piperacillin as Tazocin®), which help to minimise the risk of antimicrobial resistance
    • there is no information on how much passes into breastmilk - however, studies have not identified any concerns for their use in breastfeeding (1)

Breast milk levels

  • is limited published evidence of use in breastfeeding (1)
    • studies for amoxicillin, ampicillin, benzylpenicillin (penicillin G), flucloxacillin, phenoxymethylpenicillin (penicillin V) and piperacillin show negligible levels in breast milk
    • is no published information for pivmecillinam or temocillin, however breast milk levels are expected to be low

Infant monitoring

  • as a precaution, monitor for gastro-intestinal disturbances, oral candida infection, hypersensitivity reactions (including rashes or breathing problems), nausea, irritability, and drowsiness
    • precautionary infant monitoring will quickly pick up any potential issues
    • further investigation is usually required before any issues or side effects can be attributed to the medicine (1)
  • is a theoretical risk of hypersensitivity in the infant after exposure to penicillins through breast milk (1)
    • foetal exposure to antibiotics through the placenta may cause sensitisation
    • further exposure may result in allergic reactions, even from the negligible quantities seen in breast milk
  • therefore, as a precaution, the infant should be monitored for signs of hypersensitivity which includes rashes and breathing problem

Treatment of infant infections with penicillin based antibiotic if breastfeeding mother also on penicillin

  • if the infant needs treatment themselves with a penicillin or other antibiotic, they should receive the appropriate infant therapeutic dose, regardless of concomitant exposure through breast milk (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.